cloud based digital signage singapore

Wellteq Signs Global Agreement to Supply Digital Wellness Services to Fortune 500 US Bank Northern Trust Corporation

  • Wellteq (CSE.WTEQ) (OTCQB.WTEQF) has signed a 5-year global Master Services Agreement (MSA) to supply digital wellness services to Northern Trust Corporation (NASDAQ.NTRS) employees.
  • Northern Trust, a Fortune 500 company and leading financial services provider with more than 20,000 employees globally, is set to initiate delivery of the WellteQ Digital Health platform to employees within the Asia-Pacific region.
  • The first stage of deployment commences in Q3 2021 for employees in Singapore, Hong Kong, Australia, and the Philippines.

WellteQ Digital Health Inc. (CSE.WTEQ) (OTCQB.WTEQF) (the "Company" or "Wellteq") is pleased to announce the Company has signed a global Master Services Agreement for 5 years with Northern Trust Corporation, a leading provider of wealth management, asset servicing, asset management and banking to corporations, institutions, families, and individuals.

Companies invest into preventative or corrective health services for their workforces to improve employee health, workplace culture and team engagement and to reduce employee related costs such as absenteeism and preventable healthcare risk, preventable care utilization, and related care expenditures. A 2010 study published by Harvard University: Health Affairs estimated that, for every dollar spent on corporate wellness programs, medical costs fell by approximately $3.27 and absenteeism costs fell by about $2.73 for every dollar spent. 1 With such quantifiable benefits, the industry is projected to grow to over US $90 billion annually by the end of 2026. 2

Through its smartphone application, Wellteq offers personalized wellness, risk reduction, illness prevention and digital coaching capabilities to employees in over 30 countries and 12 languages. Wellteq's capabilities are seamlessly integrated with wearables, such as Garmin (NASDAQ.GRMN), Apple Watch (NASDAQ.AAPL) and Fitbit (NASDAQ.GOOGL), and with rewards, incentives and telemedicine partners.

As a banking institution with offices across the United States and 23 locations in Canada, Europe, the Middle East, and the Asia-Pacific region, Northern Trust has recognized the importance of offering localized employee wellness solutions to their regional teams. The first wave of the Wellteq deployment offers Wellteq's digital health platform to Northern Trust's Asia Pacific employees in Singapore, Hong Kong, Australia and the Philippines commencing in Q3, 2021.

Wellteq CEO Scott Montgomery stated, "Wellbeing is more essential than ever. While employees try to cope with drastic and rapid workplace changes and professional stresses, employers need to find new tools to help support employees. A recent survey from the Centers for Disease Control and Prevention found that 41% of all U.S. adults are struggling with mental health 3 stemming from the COVID-19 pandemic. Wellteq's behaviour change support programs offer credible health information and digital coaching across sleep, activity, mindset and nutritional habits and we're working with forward-thinking organizations like Northern Trust that genuinely care to help their teams survive and thrive in this new normal."

"We are deeply committed in supporting our employees and encourage holistic wellbeing," said Angelo Calvitto, Head of Asia Pacific, Northern Trust. "Wellteq complements the extensive suite of benefits and resources we provide our employees and will help bring them the most relevant resources to boost their physical, emotional, and financial health while at work and at home."

About Wellteq

Wellteq Digital Health Inc. is a leading provider of personalized digital health and wellness solutions across the Continuum of Care. To learn more, visit https://www.wellteq.co .

About Northern Trust

Northern Trust Corporation (NASDAQ.NTRS) is a leading provider of wealth management, asset servicing, asset management and banking to corporations, institutions, affluent families and individuals. Founded in Chicago in 1889, Northern Trust has a global presence with offices in 22 U.S. states and Washington, D.C., and across 23 locations in Canada, Europe, the Middle East and the Asia-Pacific region. As of March 31, 2021, Northern Trust had assets under custody/administration of US$14.8 trillion, and assets under management of US$1.4 trillion. For more than 130 years, Northern Trust has earned distinction as an industry leader for exceptional service, financial expertise, integrity and innovation. Please visit our website or follow us on Twitter . Northern Trust Corporation, Head Office: 50 South La Salle Street, Chicago, Illinois 60603 U.S.A., incorporated with limited liability in the U.S. Please read our global and regulatory information .

Cautionary Note Regarding Forward-Looking Statements:

This news release contains information or statements that constitute "forward-looking statements." These statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements, or developments to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. These statements that are not historical facts and are generally, but not always, identified by words such as "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," "potential" and similar expressions, or that events or conditions "will," "would," "may," "could" or "should" occur.

These statements made in this news release are based on management's assumptions and analysis and other factors that may be drawn upon by management to form conclusions and make forecasts or projections, including management's experience and assessments of historical trends, current conditions and expected future developments. Although management believes that these assumptions, analyses and assessments are reasonable at the time the statements contained in this news release are made, actual results may differ materially from those projected in any forward-looking statements.

The forward-looking information contained in this news release represents the expectations of Wellteq as of the date of this news release and, accordingly, is subject to change after such date.

The CSE has neither approved nor disapproved the contents of this news release.


1 Harvard University: Health Affairs. "Workplace Wellness Programs Can Generate Savings." February 2010.

2 MarketsandMarkets Research Private Ltd. "Corporate Wellness Solutions Market Worth $94.6 billion by 2026 – Exclusive Report by MarketsandMarkets." June 2021.

3 Mark É. Czeisler et al. "Mental health, substance use, and suicidal ideation during the COVID-19 pandemic—United States, June 24–30, 2020," Morbidity and Mortality Weekly Report, August 14, 2020; Volume 69, Number 32, pp. 1049–57, cdc.gov.

Glen Akselrod
Bristol Investor Relations
glen@bristolir.com
T: (905) 326-1888 ext 1

News Provided by Business Wire via QuoteMedia

The Conversation (0)
  BPH Global Ltd

Notice of Extraordinary General Meeting/Proxy Form

Notice is hereby given that an Extraordinary General Meeting of Shareholders of BPH Global Limited ACN 009 104 330 will be held at 3:00pm AEST on 24 May 2024 at Suite 5, Level 12, 530 Collins Street, Melbourne VIC 3000 (Meeting).

Keep reading...Show less
Genes and chromosomes with "2024" overlay.

Biotech Market Update: Q1 2024 in Review

The first quarter of 2024 witnessed a surge in initial public offerings (IPOs) and mergers and acquisitions (M&A) within the biotech industry, signaling continued interest from investors.

AstraZeneca’s acquisition of start-up Amolyt on March 14, and its longtime biotech partner Fusion Pharmaceuticals for US$2.4 billion on March 19 marked the third acquisition of a radiopharmaceutical developer in recent months. As of writing, there have been 14 M&A deals struck in 2024, according to data from Biopharma Dive.

Investment bank Jefferies released data in early March revealing that the sector was on track to earn its highest quarterly total in three years, reflecting the cautiously optimistic outlook at this year's JPM24 conference.

Keep reading...Show less

AMGEN TO PRESENT TEZSPIRE® PHASE 2A COPD DATA AT ATS 2024

Planning Underway for Phase 3 Development of Tezepelumab in COPD

Amgen (NASDAQ:AMGN) today provided an update regarding the results of the Phase 2a COURSE trial for TEZSPIRE ® (tezepelumab-ekko) in chronic obstructive pulmonary disease (COPD), which were accepted for presentation in the Clinical Trials Symposium at The American Thoracic Society (ATS) 2024 International Conference on Monday, May 20 from 9:15-11:15 a.m. PDT .

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less
Close up 3D rendering of DNA strands.

Biotech Stocks: 5 Biggest Companies in 2024

What are the top biotech companies? The following five stocks have market capitalizations worth billions of dollars and operate in countries all around the globe.

Plus, these big-name biotech players have pipelines stuffed with potentially disruptive products — and enough revenue to recover should some of those products fail.

This means that investors can experience the excitement of biotech investing while minimizing risk. Although returns are never guaranteed, company size can insulate investors from volatility.

Keep reading...Show less
SIRONA BIOCHEM Corporate Update April 2024

SIRONA BIOCHEM Corporate Update April 2024

Sirona Biochem Corp . (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (" Sirona " or the " Company ") provides the following update:

Dear shareholders,

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Sirona Biochem Announces Close of Private Placement

Sirona Biochem Announces Close of Private Placement

Vancouver, British Columbia – April 4, 2024 Sirona Biochem Corp . (TSX-V: SBM) (Frankfurt: ZSB) (" Sirona ") has closed its private placement (Private Placement") for gross proceeds of $132,500 CAD. The Private Placement consists of 1,325,000 units, (the "Units") at a price of $0.10 per Unit. Each Unit consists of one common share and one transferable share purchase warrant, each whole warrant exercisable into one additional common share of the Company for a period of 2 years from the date of issue at a price of $0.15 per Share in year one and $0.25 per Share in year two. All securities issued under the Private Placement are subject to statutory hold periods expiring on August 4, 2024.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×